Transforming Medicine Through Innovation
and Design Thinking
12:00 PM - 1:00 PM
CBSSM Seminar Series: Disparities in the Quality of Cancer Care
Thursday, November 20
3:00 PM - 4:00 PM
Building 16, NCRC
Friday, November 21
2:00 PM - 3:15 PM
Cure Room, Room #5050
Brehm Tower, 5th Floor
EndNote for Academic Research and Publishing for the Health Sciences
Wednesday, December 3
9:00 AM - 11:00 AM
2802 Med Sci II Bldg
Working with Industry: How, When, & Why?
5:30 PM - 7:00 PM
G063 and G064
Building 10, NCRC
Building Strong Training and Research Collaboration:
A Novel South-South and South-North Partnership
Danto Auditorium, CVC
Please RSVP by Wednesday, December 3.
The Secrets of Non-Disclosure Agreements
12:30 PM - 1:30 PM
Project Route Map
Wednesday, January 7
8:00 AM - 10:00 AM
BSRB Seminar Rooms
Please note that this workshop is for faculty only.
for Biomedical Research Discoveries
Wednesday, January 14
5:30 PM - 7:00 PM
Room #5515, BSRB
Positive Technology: Utilizing Mobile Devices for Psychosocial Intervention
Thursday, March 26 - Friday, March 27
U-M Institute for
Conference is free, but registration is required. Register early, we only have space for 50 participants.
2015 Conference on Adolescent Health
Thursday, April 23 - Friday, April 24
Ann Arbor Marriott Ypsilanti at Eagle Crest
Call for poster proposal abstracts due by Friday, December 12 at 5:00 PM. Additional details available here.
Health System Headlines Research Seminars & Events
|FUNDING + AWARD OPPORTUNITIES |
Monday, December 15
Jr. Foundation - Mallinckrodt
Thursday, November 20
George O'Brien Michigan Kidney Translational Core Center Pilot Program
Monday, November 24
CDNM Pilot Grants
Monday, December 1
for Sleep Research
Thursday, December 4
MTRAC Kickstart Award
Proposals will be reviewed on a rolling basis until available funding has been distributed.
Radiology/Nuclear Medicine Seed Grants for Advancing
Clinical Use of Pet Radiopharmaceuticals
Proposals will be reviewed on a rolling basis.
Award for Spinal Cord Research
Sunday, November 30
Cancer Research Foundation
Physician-Scientist Training Award
Monday, December 1
Monday, January 12
Monday, January 12
|RESEARCH NEWS |
A Year of Exciting Progress
Plans to transform the clinical trial enterprise announced at Research Town Hall
The Research Board of Directors (RBOD), Medical School leadership, and the Medical School Office of Research are always actively listening to research faculty and staff with the ultimate goal of increasing the pace and success of biomedical research at the University of Michigan.
At the Research Town Hall on Wednesday, November 5, Senior Associate Dean for Research Steven L. Kunkel, Ph.D., offered a brief outline of how the entire research enterprise has been acting on faculty and staff feedback by pushing forward the elements of the Strategic Research Initiative.
Bolstering infrastructure and scientific enablers is a key "fast forward" strategy of the Strategic Research Initiative, and great strides have been made in the past year. Click on the links below to explore these areas further, or CLICK HERE to view the video of the Research Town Hall where milestones were discussed in further detail.
In addition to these significant areas of progress and investment, Dean Kunkel also announced the start of another major fast forward strategy - transforming the clinical trial enterprise.
Earlier this year, a Clinical Trials Task Force was convened by the RBOD and charged with mapping out a strategy for system-wide improvements to clinical trials research here at the U-M Medical School and Health System. Members of the Clinical Trials Task Force are:
- David Pinsky, Co-Chair
- Robert Neumar, Co-Chair
- John Carpenter
- John Carethers
- Reed Dunnick
- Ed Hurvitz
- Steve Kunkel
- Ted Lawrence
- Paul Lee
- Karin Muraszko
- Mack Ruffin
- Tom Shanley
- Max Wicha
After several months of fact-finding and planning, last month the RBOD officially approved and provided a multi-million dollar funding budget for the Task Force's strategic and tactical recommendations. Between now and January 2018, the entire research enterprise will engage in overhauling clinical trials, including:
- Enhancing infrastructure by unifying policies and developing common standards, tools, and metrics
- Mandatory training and professionalization of the Study Coordinator role
- Streamlining regulatory review and contracting
- Developing and deploying a clinical trial management system
- Enhanced and efficient identification of research participants and active trials
- Revise promotion, tenure, and compensation to acknowledge importance and value of clinical trial activities
- Identify space within or near clinics to fully integrate the clinical and research experience for patients
Other changes will include work toward building a collaborative, federated system of thematic and flexible operational nodes, where local clinical trial management will occur and be executed. All investigators will have access to these nodes for support for their clinical trial portfolio. The nodes will be responsible to the RBOD Clinical Trial Subcommittee and will provide ongoing performance metrics.
The Research Town Hall video contains a more detailed outline of the recommendations of the Clinical Trials Task Force.
MCubed Launches Donor-Funded Diamond Program
All Medical School faculty will receive an MCubed Diamond token
With over $1 million in gifts, a new phase of the MCubed research funding program recently launched, broadening the scope of U-M's unique initiative to advance bold work that crosses traditional academic boundaries.
In the MCubed Diamond program
, named after the shape of the tokens qualifying researchers will receive, individuals or organizations pay for a project that a faculty member will steer. Donors fund MCubed projects on topics that are important to them, and the funders of these projects can be anyone - alumni, foundations, or companies.
Seven Diamond projects were announced as part of the launch: two projects relating to health, education and improving economic outcomes for women and children in developing countries, and five projects using big data sets beyond the healthcare and medical fields. New projects will be announced on a rolling basis.
Unlike the pilot phase of MCubed, no matching funding from researchers or their departments is required. Diamond cubes are fully financed by the external organizations. Just as in the previous incarnation of the program, the money the researchers receive - $60,000 for each cube - pays for a student's or postdoctoral researcher's salary to conduct the research.
"We're ecstatic about opening this phase of the program," said Mark Burns, MCubed director. "It gives our faculty another opportunity to push forward high risk/high reward research that might not otherwise get funded. And it gives anyone in the world the chance to have U-M researchers work on their projects."
is U-M's unique interdisciplinary research funding experiment designed to encourage new collaborations and innovative projects. Since it started in 2012, the program has given more than $13 million in early-stage grants to more than 200 trios of researchers.
BRCF Announces 2014 Holiday Hours
As in past years, the Biomedical Research Core Facilities will have special holiday hours to allow staff members to use their University Season Days. The holiday hours for the Cores are now available online.
A New Face in the UMMS Office of Research
UMMS OoR welcomes new Senior Manager of Research Development Support
The U-M Medical School (UMMS) Office of Research is pleased to welcome Jill Jividen, who will serve as Senior Manager of Research Development Support, to the UMMS Office of Research team.
In this role, Jill will lead and develop educational training programs in grant proposal development for the UMMS research community, including conducting proposal writing workshops and overseeing the Mentored Research Academy: R01 Boot Camp program, now in its second year.
She will also develop new programs and resources to assist faculty with successfully securing funding from various sponsors, as well as work to connect investigators to existing proposal development and funding resources.
Jill has been with the University of Michigan for more than four years, most recently as the Program Director for Faculty Research Development at the Institute for Research on Women and Gender. Previous stints at both the UMMS and the School of Information have allowed Jill to hone her skills in grants administration, particularly in proposal development for a broad range of both federal and private sponsors.
Her experience includes extensive opportunities to advise faculty in funding opportunities, proposal processes, award administration, and career development. Jill earned her Ph.D. in English from the University of South Carolina in 2008.
Please join us in welcoming Jill to the UMMS Office of Research!
Medicine at Michigan Seeking Books Authored by UMMS Faculty
Medicine at Michigan is seeking news of books authored or edited by Medical School faculty - or guest editorship of a full journal issue - for the "In Print" section of the magazine's next issue.
Please send publication information, including title, co-authors/editors, publisher and publication date, to Lauren Crawford at [email protected] by Wednesday, November 26 for inclusion in the upcoming issue.
If possible, please also send a high-resolution image of the cover or forward the book or journal to Lauren Crawford at the UMHS Office of Development, 1000 Oakbrook, Suite 100, Ann Arbor, 48104-6815.
If a physical copy is submitted, the cover will be scanned to print specifications. Please also indicate if you would like your items returned after scanning.
Office of Faculty Affairs & Faculty Development Launches New Website
Guide to Open Access and Publishing Your Work -- SAFELY
Every day, researchers and administrators at the university receive invitations to contribute to journals. Many of these solicitations are from publishers of Open Access (OA) Journals.
While there are many reputable OA journals, there are also a growing number of so-called "predatory journals" - those that exist solely for the purpose of generating revenue rather than further scholarship. Since OA journals utilize a different funding model than traditional subscription-based journals, working with them can involve a learning curve.
The University Library has a newly updated and useful Research Guide explaining Open Access. Contents include: factors that influence a researcher's choice of publications options, considering one's funding source, funding amounts, and the issues of securing tenure or promotion, and tips on how to find reputable journals in which to publish your work.
Apply Now for Help with Your Winter Semester Research Project
The Undergraduate Research Opportunity Program (UROP) has admitted a group of students who will be ready to start working on research projects during the winter semester.
We need lab, clinical, and public health projects for these students. If you could use help collecting pilot data or with your current research project, please fill out the short online application by mid-November.
This will give students time to contact you so that you can schedule interviews and make your decision before winter break. You can also provide background material so students will be ready to start working the week of January 5th.
UROP is not a match program. Instead, UROP provides a list of approved projects, and interested students contact the researcher directly. You decide who you want to interview and who you want to offer the position to.
Supplemental funding of $500 - $1000 per project is available for student research-related costs.
Contact Katy Downs, UROP Assistant Director, at (734) 615-9000 or [email protected]. Additional program details can also be found on the UROP website.
Faculty Panel to Explore Ways to Leverage U-M Excellence in Biosciences
Panel includes several UMMS faculty members
During his keynote address to open the 2014 MCubed Symposium, President Mark S. Schlissel said he will work with faculty to develop strategies that will allow the university to fully take advantage of the excellence spread among its schools, colleges, institutes and other academic centers.
"In other words, how do we make our strength greater than the sum of our many excellent parts?" he asked.
As a first step, President Schlissel announced he would convene a panel of distinguished U-M faculty members to focus on the biological sciences. The President's Advisory Panel on the Biosciences will develop a research and education strategy that leverages the university's strengths in the life sciences.
The 17-member panel is chaired by Provost Martha E. Pollack and includes leading faculty members across a range of disciplines from biology, chemistry and psychology to the neurosciences, math, and biomedical engineering.
The official charge to the panel reads, in part, "The overarching challenge is how to develop and then implement a life sciences research and education strategy that reaches across the entire enterprise, permeabilizes the barriers that exist between departments and schools, and allows us to make synergistic investments in faculty, students, and infrastructure that enhance the excellence and impact of research at the university. Put simply: How do we make the whole greater than the sum of its parts?"
The panel will begin its work immediately with an interim report due to the president by February 1, 2015. A final set of recommendations will be due by the end of the 2015 winter semester.
Dean Woolliscroft Honors 2014 League of Research Excellence
On Monday night, Dean James O. Woolliscroft, M.D., honored a select group of Medical School faculty with induction into the League of Research Excellence. Since 2011, the League of Research Excellence has celebrated the phenomenal success of the U-M Medical School's elite research faculty.
The faculty selected this year for the League of Research Excellence are those that have demonstrated research excellence in all or one of the following areas: collaborations and team science, publications, seminal discoveries, entrepreneurial endeavors, and national/international prominence in his/her field.
Adding 49 faculty scientists and physicians to the League, the entire Medical School community is inspired and proud of the accomplishments of this stellar group, and immensely appreciative of the quality and quantity of their work.
Click here to view the complete list of 2014 League inductees.
Seeking Nominations for 2015 Distinguished University Innovator Award
Deadline for nominations: Friday, December 5
|2014 Distinguished University Innovator Award Winner Shaomeng Wang,|
Established in 2007, the Distinguished University
is the University's highest honor for faculty who have shown leadership in bringing new ideas to the marketplace.
Sponsored by the U-M Office of Research
, this award not only allows us to honor the accomplishments of members of our community who have made a difference in this arena, but it also inspires others to follow in their footsteps.
Additional details on award criteria, the nomination and selection processes, and previous winners can be found here.
Nominations are due on Friday, December 5, and the selection will be announced in February 2015.
Please contact the U-M Office of Research at (734) 763-1290
with questions about the program.
Dean Woolliscroft Wins
National Award for Leadership in Medical Education
At the recent annual meeting of the Association of American Medical Colleges (AAMC) in Chicago, U-M Medical School Dean James O. Woolliscroft, M.D., who has led the school since 2007, accepted the Flexner Award in recognition of outstanding leadership in transforming medical education in the modern age.
Considered the highest honor given by AAMC, the Flexner Award recognizes extraordinary contributions to medical schools and the medical education community, and was first given in 1958.
In nominating Dean Woolliscroft for the honor, George Thibault, M.D., president of the Josiah Macy Jr. Foundation, wrote, "He has been consistently ahead of his time and often prophetic about the trends in medical education."
Read more about Dean Woolliscroft's nomination.
Six U-M Faculty Elected to Prestigious Institute of Medicine
Click on the image above to read more about each faculty member's research.
University of Michigan experts in genetic and statistical analysis, Lou Gehrig's Disease (ALS), head and neck cancer, health policy and nursing are among the new members of the Institute of Medicine (IOM) of the National Academies, one of the highest honors in the fields of health and medicine.
Gonšalo Abecasis, Carol Bradford, Eva Feldman, Mark Fendrick, Susan Murphy, and Kathleen Potempa were elected to the IOM in recognition of their major contributions to the advancement of the medical sciences, health care, and public health. With their election, the U-M now has 59 past and present members of the IOM.
Common Questions about the A1 - A0 Submission Process
Sharpening Your Focus:
Tips on Grant Proposal Preparation
By Chris Black, M.L.S., Assistant Director for Research Development Support,
U-M Medical School Office of Research
(One in a series of tips published in UMMS Research News about writing proposals.)
If your A1 submission to the National Institutes of Health (NIH) is not funded, and you decide to resubmit the proposal as a new application (A0), here are some common questions and answers:
- Does ≥ 50% of the content of the A0 have to be different from the A1? No, not under the new rules.
- Do I have to refer to the last summary sheets?
No, do not make any reference to the last review
(and no Introduction); the last review will not be considered/available in the Study Section. BUT be sure to incorporate the advice from the reviewers to improve
- Can I use the same title as the A1? Yes, if you like.
- May I request a different Study Section than
reviewed the A1? Yes, you may make this request if you like. Keep in mind availability of necessary expertise on the roster. CSR makes final determination and you will be notified in NIH Commons of assignment before the review.
- To whom should I speak for clarification of review
after I receive the Summary Statement
(from any submission)?
Contact the PO identified on the Summary Statement.
- Can I submit a resubmission (A1) application and new A0 based on this proposal to the same Council round? No, NIH does not allow duplicate proposals reviewed during the same cycle.
- If the unsuccessful A1 was a renewal, should I include a Progress Report in the A0?
No, these data should be presented as preliminary
or included as scientific rationale. This is no longer considered a renewal project, and must follow the
"new" proposal deadlines.
Please refer to the Resubmissions of NIH Applications FAQ page for additional details.
I've failed over and over and over again in my life and that is why
I succeed. -- Michael Jordan